Show simple item record

dc.contributor.authorKorfi, Ken_US
dc.contributor.authorMandal, Aen_US
dc.contributor.authorFurney, SJen_US
dc.contributor.authorWiseman, Den_US
dc.contributor.authorSomervaille, TCPen_US
dc.contributor.authorMarais, Ren_US
dc.date.accessioned2017-01-31T15:16:07Z
dc.date.available2015-02-17en_US
dc.date.issued2015-06en_US
dc.date.submitted2017-01-30T10:57:59.138Z
dc.identifier.issn0923-7534en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/19090
dc.description.sponsorshipKay Kendall Leukaemia Fund (KKL631) and Cancer Research UK (C15759/A12328)en_US
dc.format.extent1180 - 1187en_US
dc.language.isoenen_US
dc.relation.ispartofANNALS OF ONCOLOGYen_US
dc.rightsPublished by Oxford University Press on behalf of the European Society for Medical Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.subjectCMLen_US
dc.subjectBCRen_US
dc.subjectABL1 mutationsen_US
dc.subjectwhole-genome sequencingen_US
dc.subjectpersonalised medicineen_US
dc.subjectmechanisms of resistanceen_US
dc.titleA personalised medicine approach for ponatinib-resistant chronic myeloid leukaemiaen_US
dc.typeArticle
dc.rights.holder© The Author 2015.
dc.identifier.doi10.1093/annonc/mdv110en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357997500021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue6en_US
pubs.notesNo embargoen_US
pubs.publication-statusPublisheden_US
pubs.volume26en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record